AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17955948 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity at 30 W and 60 W for 4 min at 610 m
Number of subjects: 6
Study 15289365 — intervention group
Group type: EXPERIMENTAL
Intervention: Left bundle-branch block and intraventricular conduction delay
Number of subjects: 1638
Study 15289365 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular hypertrophy
Number of subjects: 1638
Study 15289365 — intervention group
Group type: EXPERIMENTAL
Intervention: Right bundle-branch block
Number of subjects: 1638
Study 11102555 — intervention group
Group type: EXPERIMENTAL
Intervention: Low eicosapentaenoic fish oil enriched formula
Number of subjects: 0
Study 11102555 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 0
Study 9311214 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine tape applied to patients without preanesthetic medication (group N)
Number of subjects: 90
Study 9311214 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine tape applied to patients who received 0.1 mg.kg‐1 of diazepam (group D)
Number of subjects: 90
Study 9311214 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine tape applied to patients who received 5 micrograms.kg‐1 of clonidine (group C)
Number of subjects: 90
Study 8346816 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30-60 mg IV
Number of subjects: 109
Study 8346816 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 50-100 micrograms IV
Number of subjects: 109
Study 8346816 — intervention group
Group type: COMPARATOR
Intervention: Combination of fentanyl 50-100 micrograms and ketorolac 30-60 mg IV
Number of subjects: 109
Study 3787552 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoactive intestinal peptide (1, 3, and 6 pmol/kg/min) infused for 15 minutes
Number of subjects: 0
Study 3787552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3787552 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoprenaline (400 microgram) given by inhalation after infusion
Number of subjects: 0
Study 31559638 — intervention group
Group type: EXPERIMENTAL
Intervention: CGRP monoclonal antibodies (mAbs)
Number of subjects: 0
Study 31559638 — intervention group
Group type: EXPERIMENTAL
Intervention: Ditan
Number of subjects: 0
Study 31559638 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepants
Number of subjects: 0
Study 30486868 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) combined with wearable technology
Number of subjects: 0
Study 30486868 — intervention group
Group type: COMPARATOR
Intervention: Current standard in obesity treatment
Number of subjects: 0
Study 26767548 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face group consolidation sessions
Number of subjects: 63
Study 25186159 — intervention group
Group type: EXPERIMENTAL
Intervention: Pump therapy for 2 years
Number of subjects: 280
Study 25186159 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections for 2 years
Number of subjects: 280
Study 22758620 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime PaO(2)
Number of subjects: 106
Study 22758620 — intervention group
Group type: EXPERIMENTAL
Intervention: FEV(1)
Number of subjects: 106
Study 22758620 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 106
Study 22758620 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep efficiency
Number of subjects: 106
Study 22758620 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid eye movement sleep duration
Number of subjects: 106
Study 19290686 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose beverage (target blood alcohol level = .04)
Number of subjects: 173
Study 19290686 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose beverage (target blood alcohol level = .08)
Number of subjects: 173
Study 19290686 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 173
Study 19290686 — intervention group
Group type: COMPARATOR
Intervention: Control group (no alcohol)
Number of subjects: 173
Study 17500622 — intervention group
Group type: EXPERIMENTAL
Intervention: UV photographs
Number of subjects: 0
Study 17500622 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoaging information
Number of subjects: 0
Study 17500622 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 14871515 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 80
Study 14871515 — intervention group
Group type: COMPARATOR
Intervention: Pubovaginal sling (PVS)
Number of subjects: 80
Study 12351250 — intervention group
Group type: EXPERIMENTAL
Intervention: Propacetamol 2 g IV every 6 hours for 72 hours
Number of subjects: 79
Study 12351250 — intervention group
Group type: COMPARATOR
Intervention: Placebo IV every 6 hours for 72 hours
Number of subjects: 79
Study 9440727 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (EPI) 160 mg/m2 I.V. every 3 weeks
Number of subjects: 129
Study 9440727 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin (EPI) 160 mg/m2 I.V. every 3 weeks with DEX 1,000 mg/m2 I.V.
Number of subjects: 129
Study 7985637 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg beta-carotene/d
Number of subjects: 224
Study 7985637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study 2656087 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of mifepristone + 0.5 mg gemeprost vaginal pessary
Number of subjects: 120
Study 2656087 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of mifepristone + 1 mg gemeprost vaginal pessary
Number of subjects: 120
Study 2656087 — intervention group
Group type: COMPARATOR
Intervention: 1 mg gemeprost vaginal pessary
Number of subjects: 120
Study 31928506 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 34
Study 31928506 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 34
Study 30711715 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayley-III cognitive scale
Number of subjects: 1444
Study 29151374 — intervention group
Group type: EXPERIMENTAL
Intervention: MDG oil with 6 mg lutein (FloraGLO 20%)
Number of subjects: 24
Study 29151374 — intervention group
Group type: COMPARATOR
Intervention: SAF oil with 6 mg lutein (FloraGLO 20%)
Number of subjects: 24
Study 25818496 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-and-exercise program
Number of subjects: 407
Study 25818496 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate
Number of subjects: 407
Study 25818496 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 407
Study 22882285 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous human immunoglobulin (IVIG) at a dose of 500 mg/kg
Number of subjects: 92
Study 22882285 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution, 10 mL/kg)
Number of subjects: 92
Study 22882285 — intervention group
Group type: COMPARATOR
Intervention: IVIG and Placebo
Number of subjects: 92
Study 21208228 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI integration (Group 1)
Number of subjects: 60
Study 21208228 — intervention group
Group type: EXPERIMENTAL
Intervention: ICE integration (Group 2)
Number of subjects: 60
Study 21208228 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI and ICE integration (Group 3)
Number of subjects: 60
Study 19604500 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions for insomnia
Number of subjects: 431
Study 19604500 — intervention group
Group type: EXPERIMENTAL
Intervention: Convenient treatment options
Number of subjects: 431
Study 19604500 — intervention group
Group type: EXPERIMENTAL
Intervention: Beliefs about sleep promoting behaviors
Number of subjects: 431
Study 19604500 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal beliefs about insomnia
Number of subjects: 431
Study 18091657 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic management of acute small bowel obstruction
Number of subjects: 0
Study 15180117 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative physiotherapy and education
Number of subjects: 60
Study 15180117 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative physiotherapy or educational programme)
Number of subjects: 60
Study 15180117 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (study and control)
Number of subjects: 60
Study 15450703 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving to low-poverty neighborhoods
Number of subjects: 315
Study 15450703 — intervention group
Group type: COMPARATOR
Intervention: Remaining in high-poverty neighborhoods
Number of subjects: 315
Study 11054320 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice test
Number of subjects: 25
Study 11054320 — intervention group
Group type: COMPARATOR
Intervention: Rest test
Number of subjects: 25
Study 11054320 — intervention group
Group type: COMPARATOR
Intervention: Nonmyasthenic subjects (Ice test)
Number of subjects: 25
Study 11054320 — intervention group
Group type: COMPARATOR
Intervention: Nonmyasthenic subjects (Rest test)
Number of subjects: 25
Study 9415797 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 0
Study 9415797 — intervention group
Group type: COMPARATOR
Intervention: Anxiety
Number of subjects: 0
Study 9415797 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety x Distraction interaction
Number of subjects: 0
Study 8180327 — intervention group
Group type: EXPERIMENTAL
Intervention: Reviparin-sodium (Clivarin)
Number of subjects: 498
Study 8180327 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin (Lovenox)
Number of subjects: 498
Study 3522894 — intervention group
Group type: EXPERIMENTAL
Intervention: Vidarabine 15 or 30 mg/kg/day
Number of subjects: 100
Study 3522894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 3522894 — intervention group
Group type: EXPERIMENTAL
Intervention: Vidarabine
Number of subjects: 100
Study 3522894 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (in progress)
Number of subjects: 100
Study 29797024 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical information sessions conducted by doctors
Number of subjects: 599
Study 29797024 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting)
Number of subjects: 599
Study 29797024 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical information sessions
Number of subjects: 599
Study 27532780 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-concentration fish sauce (2 g/L)
Number of subjects: 90
Study 27532780 — intervention group
Group type: EXPERIMENTAL
Intervention: High-concentration fish sauce (8 g/L)
Number of subjects: 90
Study 27532780 — intervention group
Group type: COMPARATOR
Intervention: Control (no thiamine)
Number of subjects: 90
Study 25046847 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 266
Study 22004342 — intervention group
Group type: EXPERIMENTAL
Intervention: Depth first questioning (specific occurrence first)
Number of subjects: 157
Study 22004342 — intervention group
Group type: EXPERIMENTAL
Intervention: Breadth first questioning (what usually happens first)
Number of subjects: 157
Study 22004342 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic language use in describing an occurrence
Number of subjects: 157
Study 22004342 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic language use in describing what usually happens
Number of subjects: 157
Study 22004342 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuracy rates
Number of subjects: 157
Study 20036102 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice (LAIV or TIV)
Number of subjects: 12222
Study 20036102 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice Plus (LAIV or TIV with increased advertising and nominal incentive)
Number of subjects: 12222
Study 20036102 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice Plus (TIV)
Number of subjects: 12222
Study 20036102 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 12222
Study 18201872 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinoic acid (0.025%) treatment
Number of subjects: 0
Study 18201872 — intervention group
Group type: COMPARATOR
Intervention: Loss of elastic fibers
Number of subjects: 0
Study 16613276 — intervention group
Group type: EXPERIMENTAL
Intervention: Puerarin (500mg given 1hr before anesthesia induction)
Number of subjects: 34
Study 16613276 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 34
Study 12824205 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (0.625 mg/d conjugated equine estrogens plus 2.5 mg/d medroxyprogesterone acetate)
Number of subjects: 16608
Study 10480582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 0.03% (IB)
Number of subjects: 146
Study 10480582 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate 0.042% (BDP)
Number of subjects: 146
Study 10480582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IB and BDP
Number of subjects: 146
Study 8753085 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyloroplasty (P)
Number of subjects: 67
Study 1984797 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte-depleted platelet concentrates prepared by filtration (mean leukocyte count < 5 x 10(6)/PC of 6 U)
Number of subjects: 53
Study 1984797 — intervention group
Group type: COMPARATOR
Intervention: Leukocyte-depleted platelet concentrates prepared by centrifugation (mean leukocyte count 35 x 10(6)/PC of 6 U)
Number of subjects: 53
Study 6219964 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% clindamycin phosphate combined with tretinoin gel 0.025%
Number of subjects: 64
Study 6219964 — intervention group
Group type: COMPARATOR
Intervention: Topical 1% clindamycin phosphate alone
Number of subjects: 64
Study 6219964 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin gel 0.025% alone
Number of subjects: 64
Study 31697990 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiation therapy (SAbR) boost, 28 Gy in 4 fractions
Number of subjects: 21
Study 30782227 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (multimodal antimicrobial stewardship initiative)
Number of subjects: 42
Study 28438277 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand reflexology
Number of subjects: 80
Study 28438277 — intervention group
Group type: COMPARATOR
Intervention: Simple hand massage (Control)
Number of subjects: 80
Study 28438277 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 80
Study 26357426 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Release Technique (ART)
Number of subjects: 24
Study 26357426 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint Mobilization (JM)
Number of subjects: 24
Study 26357426 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 23571179 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg‐1018 (investigational hepatitis B surface antigen vaccine with phosphorothioate oligodeoxyribonucleotide adjuvant)
Number of subjects: 0
Study 23571179 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg‐1018
Number of subjects: 0
Study 23571179 — intervention group
Group type: COMPARATOR
Intervention: HBsAg‐Eng (commercially available, alum‐adjuvanted hepatitis B vaccine)
Number of subjects: 0
Study 21228629 — intervention group
Group type: COMPARATOR
Intervention: RIX4414 vaccine stored at 2°C‐8°C (Group RIX4414-control)
Number of subjects: 218
Study 21228629 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine stored at 37°C for 7 days (Group RIX4414-37°C)
Number of subjects: 218
Study 21228629 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 218
Study 19489129 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchro-Breathe (SB)
Number of subjects: 19
Study 19489129 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumatic (VM)
Number of subjects: 19
Study 19489129 — intervention group
Group type: COMPARATOR
Intervention: Evohaler pMDI (EH)
Number of subjects: 19
Study 17557956 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months of androgen suppression therapy (AST)
Number of subjects: 1372
Study 17557956 — intervention group
Group type: COMPARATOR
Intervention: 3 months of androgen suppression therapy (AST)
Number of subjects: 1372
Study 15249101 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trials with appropriate randomization methods (40 articles)
Number of subjects: 92
Study 15249101 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trials without appropriate randomization methods (31 articles)
Number of subjects: 92
Study 15249101 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trials with inappropriate randomization methods (21 articles)
Number of subjects: 92
Study 15249101 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trials with blinding (33 articles)
Number of subjects: 92
Study 15249101 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trials with withdrawals/dropouts (77 articles)
Number of subjects: 92
Study 15249101 — intervention group
Group type: EXPERIMENTAL
Intervention: All trials
Number of subjects: 92
Study 15249101 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials published 1992-1996
Number of subjects: 92
Study 15249101 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials published 1997-2002
Number of subjects: 92
Study 11942874 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg (Group M10)
Number of subjects: 45
Study 11942874 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg (Group M20)
Number of subjects: 45
Study 11942874 — intervention group
Group type: COMPARATOR
Intervention: Saline (Group S)
Number of subjects: 45
Study 9556321 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie, high-protein diet plus protein hydrolysate (70 g/day) for Group 2 patients (n = 7)
Number of subjects: 15
Study 9556321 — intervention group
Group type: COMPARATOR
Intervention: High-calorie, high-protein diet for Group 1 patients (n = 8)
Number of subjects: 15
Study 7734029 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (100 micrograms) + GHRP-6 (90 micrograms)
Number of subjects: 18
Study 7734029 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (100 micrograms)
Number of subjects: 18
Study 7734029 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-6 (90 micrograms)
Number of subjects: 18
Study 2731108 — intervention group
Group type: EXPERIMENTAL
Intervention: Total carotenoids
Number of subjects: 467
Study 2731108 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta carotene
Number of subjects: 467
Study 2731108 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum carotenoid levels
Number of subjects: 467
Study 2731108 — intervention group
Group type: COMPARATOR
Intervention: Serum levels of retinol, alpha tocopherol, and retinol‐binding protein
Number of subjects: 467
Study 333644 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (5 grams intravenously administered 2-4 hours prior to organ harvesting)
Number of subjects: 50
Study 333644 — intervention group
Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 50
Study 7270725 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of gluten daily for 5 weeks
Number of subjects: 8
Study 7270725 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenge for 8 weeks
Number of subjects: 8
Study 30300282 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP‐2/mOsm on day‐1
Number of subjects: 74
Study 30300282 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP‐2/mOsm on day‐10
Number of subjects: 74
Study 30300282 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour urinary creatinine excretion and TIMP‐2/mOsm on day 1
Number of subjects: 74
Study 30300282 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour urinary creatinine excretion, TIMP‐2/mOsm, and total warm ischemia time on day 10
Number of subjects: 74
Study 29737803 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiwifruit extract (Zyactinase)
Number of subjects: 58
Study 29737803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 28127798 — intervention group
Group type: EXPERIMENTAL
Intervention: Close friend condition
Number of subjects: 131
Study 28127798 — intervention group
Group type: COMPARATOR
Intervention: Casual friend condition
Number of subjects: 131
Study 24582813 — intervention group
Group type: EXPERIMENTAL
Intervention: BQ-123 (400 nmol/min for 60 min)
Number of subjects: 30
Study 24582813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 22790978 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative autologous blood transfusion (ABT)
Number of subjects: 100
Study 22790978 — intervention group
Group type: COMPARATOR
Intervention: No drainage
Number of subjects: 100
Study 20961701 — intervention group
Group type: EXPERIMENTAL
Intervention: Perifracture site injection (PI) with local anesthetic mixture (ropivacaine, morphine, epinephrine); n = 22.
Number of subjects: 44
Study 20961701 — intervention group
Group type: COMPARATOR
Intervention: No perifracture site injection (no-PI); n = 22.
Number of subjects: 44
Study 17585025 — intervention group
Group type: EXPERIMENTAL
Intervention: Low phytate maize
Number of subjects: 53
Study 17585025 — intervention group
Group type: COMPARATOR
Intervention: Normal maize (Control)
Number of subjects: 53
Study 12736155 — intervention group
Group type: EXPERIMENTAL
Intervention: l-arginine (1 g/min for 30 min) with insulin (6 mU x kg(‐1) x min(‐1) for 120 min)
Number of subjects: 23
Study 12736155 — intervention group
Group type: COMPARATOR
Intervention: l-arginine (1 g/min for 30 min) without insulin
Number of subjects: 23
Study 12736155 — intervention group
Group type: COMPARATOR
Intervention: d-arginine (1 g/min for 30 min)
Number of subjects: 23
Study 12736155 — intervention group
Group type: EXPERIMENTAL
Intervention: l-arginine with insulin (1.5 mU x kg(‐1) x min(‐1))
Number of subjects: 23
Study 11050518 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg i.v. (group 1)
Number of subjects: 90
Study 11050518 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg i.v. (group 2)
Number of subjects: 90
Study 11050518 — intervention group
Group type: EXPERIMENTAL
Intervention: Both droperidol and ondansetron (group 3)
Number of subjects: 90